ITT Inc.: Strong Growth, but Is the Premium Multiple Worth the Acquisition Risk?

ITT Inc. reported one of the strongest quarters of its recent history in August 2026. Revenue hit a record $1.47 billion, organic growth came in at 13% year-over-year, adjusted EPS rose 18% to $2.08, and management raised full-year guidance across revenue, margins, and earnings. By every conventional measure, it was the kind of earnings report that sends stocks higher.

Instead, ITT's shares have pulled back roughly 8.6% over the past month, trading around $198 — well below its 52-week high near $230. The market is pricing in a question that the earnings report itself doesn't answer: at a forward P/E of roughly 39x and EV/EBITDA of 23x, does ITT's growth story still justify a premium multiple after taking on nearly $6.2 billion in total debt to fund its acquisition of SPX Flow?

The SPX Flow deal closed in March 2026 for $4.775 billion, structured as a mix of cash, debt, and equity. ITT issued $777 million in stock to Lone Star Funds and drew on a $2.875 billion term loan facility. The acquisition roughly doubled ITT's debt load — total debt rose from about $2 billion in early 2026 to over $6 billion after the deal. Net debt stands at approximately $3.14 billion, and the debt-to-equity ratio jumped from 0.42x to 0.78x in just a couple of quarters.

All of this happened against a backdrop of impressive operating growth. Q2 2026 organic revenue grew 13%, orders grew 13% organically, and adjusted operating margins expanded 40 basis points. The Flow Technologies segment — where SPX Flow was integrated — delivered 21% organic revenue growth. CCT (Critical & Commercial Technologies) held strength in aerospace and defense. Motion Technologies outpaced global vehicle production. And ITT raised its full-year organic revenue guidance to 5-8%, with adjusted EPS guidance at an $8.22 midpoint.

But here's where the tension between quality and valuation becomes visible. Despite the organic growth, GAAP operating margins actually fell to 12.2% in Q2 from 18% in the prior-year quarter, largely due to $62.6 million in intangible amortization tied to the SPX Flow acquisition. The company has committed to $80 million in cost synergies by year three, and management says the deal is immediately accretive to gross and adjusted EBITDA margins, but the road from announcement to realized synergy is long, and the balance sheet is now materially more levered.

The stock is trading at a forward P/E of roughly 39x and an EV/EBITDA multiple of 23x. For comparison, Xylem — a spinoff peer in the flow technologies space — trades at about 25x P/E and 17x EV/EBITDA. Rockwell Automation, in the industrial automation space, is at roughly 39x P/E but 27x EV/EBITDA. Eastman Chemical is much cheaper at 18x P/E and 10x EV/EBITDA, but operates in a different part of the cycle. ITT sits in an uncomfortable middle: it's paying premium industrial multiples for a business that is still proving the SPX Flow integration story while carrying significantly more debt.

The free cash flow story provides some comfort but also reveals the tension. TTM free cash flow is about $509 million against an enterprise value of roughly $21 billion, which implies a free cash flow yield of roughly 2.4%. The dividend yield is 0.73%, and ITT has 24 consecutive years of dividend payments. Free cash flow grew 4.4% year-over-year in the TTM window, but capital intensity is manageable at roughly $123 million in capex — the company isn't a capital hog, but the FCF yield doesn't stretch far to justify the multiple after acquisition.

So what would need to happen for the premium multiple to make sense? The market needs to see the SPX Flow synergies materialize faster than expected, with cost savings of $80 million annually flowing into earnings, driving margin expansion that compounds the organic growth trajectory. ITT management has signaled that adjusted EPS is expected to be accretive in 2026, with double-digit EPS accretion anticipated in the first full year post-close (excluding intangible amortization). The integration is described as "ahead of plan", and cost synergies are tracking ahead of the initial timeline.

But the risk is real and concrete. A company that has tripled its debt burden to execute a large acquisition needs flawless execution over the next two to four quarters. Any stumble — slower-than-expected synergy realization, integration execution issues, deceleration in organic growth, or macro pressure on industrial demand — would compound the valuation concern. At 39x forward earnings, there is limited margin for error. The stock doesn't have the luxury of being cheap enough to absorb a miss.

Q3 2026 earnings in late October will be the next key test. Investors will be watching for signs that the SPX Flow integration is generating expected margin improvements, that organic order momentum continues across all three segments, and that the leverage profile is moving toward management's stated target of below 2.0x net leverage within 18 months post-close.

For a company with genuine operating strength, the disconnect between strong execution and rich valuation is the story. ITT is not a broken business — it has real organic growth, a diversified platform, and a management team with a demonstrated track record under CEO Luca Savi. But growth alone doesn't justify a premium multiple when the balance sheet has taken on significant leverage and the execution clock is ticking. The stock needs the SPX Flow story to play out exactly as management envisions, with no material setbacks, for the current multiple to be defended.

For investors watching from the sidelines, the prudent approach is to wait for proof. The valuation doesn't absorb enough execution risk at these levels. A pullback toward fair value — or clear evidence in the Q3 print that synergies are accelerating and margins are expanding as promised — would be a more compelling entry point. Until then, the market's caution after strong earnings reflects a rational calculation: great operating results at a premium multiple still carry meaningful downside if the acquisition story falters.